MJBizDaily
Why a cannabis business is betting on dogs to reach FDA approval
Latest Posts
Marijuana reform competes with coronavirus, recession for attention from Congress
Congressman Earl Blumenauer has been the tip of the spear for decades when it comes to marijuana reform in the U.S. House of Representatives. But he’s never been as optimistic…
News March 1
Cannabis businesses can shield against product-liability claims by managing supply chain
Product-liability cases are among the most damaging lawsuits a business can face. Yet many marijuana businesses don’t take this threat as seriously as they should, experts said.
News February 28
Virginia lawmakers approve recreational marijuana legalization
Virginia lawmakers on Saturday narrowly approved compromise legislation legalizing a commercial recreational marijuana program that could generate nearly $1.5 billion in annual sales within five years of the scheduled Jan.…
News February 27
VA lawmakers scramble to agree on adult-use marijuana bill before deadline
Legislative negotiations in Virginia to resolve differences over two adult-use marijuana bills are down to the wire.
News February 26
Michigan loosens eligibility demands for recreational cannabis licenses
Michigan's recreational cannabis market will open up to new competition beginning March 1, when applicants for multiple classes of adult-use marijuana licenses will no longer require an active medical MJ…
News February 26
California marijuana testing lab sues state over revoked license
A San Francisco Bay Area marijuana testing lab whose business license was revoked earlier this month filed suit against California regulators, claiming its right to due process was violated because…
News February 26
Ascend acquires most of MedMen’s NY cannabis operation for $63 million
Massachusetts-based Ascend Wellness Holdings is acquiring an 86.7% interest in financially strapped MedMen Enterprise’s cannabis operation in New York for $63 million, according to a definitive agreement announced Friday.
News February 26
Moldy cannabis gummies, mislabeled pre-rolls recalled in Canada
Regulated Canadian cannabis products recalled in February include potentially moldy THC-infused edibles, plus two different instances of pre-rolled joints with incorrect cannabinoid labeling. The edibles recall involves one lot of…
News February 26
Cannabis producer Cronos loses $111.7 million in fourth quarter
Canadian cannabis producer Cronos Group reported a quarterly loss of $111.7 million and an adjusted EBITDA of negative $53.1 million, according to the full-year and fourth-quarter results released Friday, well…
News February 26
Latest Sponsored
